Renoprotective Effects of the New T-type Calcium Channel Blocker R(-)efonidipine in Comparison to Efonidipine and Irbesartan in Salt-loaded Hypertensive Rats

被引：0
|
作者：
Hu, Chunyan [1 ]
Mori, Takefumi [1 ]
Lu, Yi [1 ]
Yoneki, Yoshimi [1 ]
Ito, Sadayoshi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan
来源：
FASEB JOURNAL | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury
    Kawabata, M
    Ogawa, T
    Han, WH
    Takabatake, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (09): : 674 - 679
  • [22] The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium
    Tanaka, H
    Komikado, C
    Shimada, H
    Takeda, K
    Namekata, I
    Kawanishi, T
    Shigenobu, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 96 (04) : 499 - 501
  • [23] Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca2+ regulation in iron-overloaded thalassemic mice
    Khamseekaew, Juthamas
    Kumfu, Sirinart
    Palee, Siripong
    Wongjaikam, Suwakon
    Srichairatanakool, Somdet
    Fucharoen, Suthat
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    CELL CALCIUM, 2018, 72 : 18 - 25
  • [24] The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea-pig ventricular myocardium
    Komikado, C
    Shimada, H
    Takeda, K
    Namekata, I
    Kawanisi, T
    Tanaka, H
    Shigenobu, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 234P - 234P
  • [25] Protective Effects of Efonidipine, a T and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy
    Sasaki, Hidehisa
    Saiki, Atsuhito
    Endo, Kei
    Ban, Noriko
    Yamaguchi, Takashi
    Kawana, Hidetoshi
    Nagayama, Daizi
    Ohhira, Masahiro
    Oyama, Tomokazu
    Miyashita, Yoh
    Shirai, Kohji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (05) : 568 - 575
  • [26] Effects of efonidipine, an L- and T-type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: An uncontrolled, open-label pilot study
    Shimizu, M
    Ogawa, K
    Sasaki, H
    Uehara, Y
    Otsuka, Y
    Okumura, H
    Kusaka, M
    Hasuda, T
    Yamada, T
    Mochizuki, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2003, 64 (09): : 707 - 714
  • [27] The safety and efficacy of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in indian patients with mild-to-moderate essential hypertension
    Jariwala, P.
    Kartik, Jadhav
    EUROPEAN HEART JOURNAL, 2022, 43
  • [28] Low dose T-TYPE calcium channel blocker efonidipine reduced renal vascular fibrosis and inflammations by TGF-β1 inhibition in prolonged L-name/SHR
    Kameda, Tomoko
    Ono, Hidehiko
    Akashiba, Akira
    Takahashi, Toshiaki
    Ono, Yuko
    Ishimitsu, Toshihiko
    Matsuoka, Hiroaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 343 - 343
  • [29] Benefit of dual L plus T type calcium channels blockade, efonidipine, on the treatment of hypertension: Comparison with other type calcium channel blockades
    Geshi, E
    Koba, S
    Suzuki, H
    Iso, Y
    Saitoh, T
    Katagiri, T
    JOURNAL OF HYPERTENSION, 2002, 20 : S161 - S161
  • [30] Renoprotective effects of the N- and L-type calcium channel blocker cilnidipine in combination with an angiotensin II type 1 receptor blocker in Dahl salt-sensitive hypertensive rats
    Aritomi, Shizuka
    Konda, Tomoyuki
    Wagatsuma, Hirotaka
    Koganei, Hajime
    Mitsui, Akira
    JOURNAL OF HYPERTENSION, 2006, 24 : 292 - 292
12345